Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ethical issues in human prion diseases.

S J Tabrizi1, C L Elliott, C Weissmann

  • 1Department of Neurodegenerative Disease/MRC Prion Unit, Institute of Neurology, London, UK.

British Medical Bulletin
|October 3, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decoding Huntington's disease: a global survey on symptoms and genetic testing practices.

European archives of psychiatry and clinical neuroscience·2025
Same author

Apathy predicts rate of cognitive decline over 24 months in premanifest Huntington's disease.

Psychological medicine·2020
Same author

Predictors for a dementia gene mutation based on gene-panel next-generation sequencing of a large dementia referral series.

Molecular psychiatry·2018
Same author

Huntington's disease: a clinical review.

European journal of neurology·2017
Same author

The reliability of commonly used electrophysiology measures.

Brain stimulation·2017
Same author

A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease.

Human molecular genetics·2014
Same journal

Augmentation in Achilles tendon repair: evidence versus enthusiasm.

British medical bulletin·2026
Same journal

Regional musculoskeletal pain in workers-is the traditional medical model increasing disability?

British medical bulletin·2026
Same journal

Human health in relation to visible, functional, and accessible green space: a systematic review and narrative synthesis of the 3 + 30 + 300 guideline.

British medical bulletin·2026
Same journal

Muscle herniae in exercise-induced leg pain: diagnostic pitfalls and the 'repair paradox'.

British medical bulletin·2026
Same journal

Scaffolds and platelet concentrates in bone regenerative medicine: applications, mechanisms, and future approaches.

British medical bulletin·2026
Same journal

Back squat and deadlift fatiguing protocols elicit distinct countermovement jump profiles: phase-specific predictors and soreness responses.

British medical bulletin·2026
See all related articles

Prion diseases, incurable neurodegenerative conditions, present significant ethical challenges in research, diagnosis, and treatment. Addressing these ethical questions is crucial for managing transmissible spongiform encephalopathies in humans and animals.

Area of Science:

  • Neuroscience
  • Pathology
  • Bioethics

Background:

  • Prion diseases, or transmissible spongiform encephalopathies (TSEs), are fatal neurodegenerative disorders affecting both humans and animals.
  • Recent outbreaks, including Bovine Spongiform Encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD) in humans, have heightened public and scientific concern.
  • These diseases are characterized by their transmissibility and lack of a cure, necessitating careful consideration of ethical implications.

Purpose of the Study:

  • To identify and discuss the key ethical questions arising from research into prion diseases.
  • To examine the ethical considerations surrounding diagnostic procedures for transmissible spongiform encephalopathies.
  • To explore the ethical dilemmas associated with therapeutic interventions for incurable prion-related conditions.
Keywords:
Biomedical and Behavioral ResearchGenetics and ReproductionHealth Care and Public Health

Related Experiment Videos

Main Methods:

  • Literature review of ethical frameworks relevant to neurodegenerative diseases.
  • Analysis of case studies and public health responses to prion disease outbreaks.
  • Synthesis of ethical principles applied to medical research, diagnostics, and patient care.

Main Results:

  • Ethical concerns include informed consent for research participation and diagnostic testing.
  • Questions arise regarding resource allocation for incurable diseases and the potential for iatrogenic transmission.
  • Balancing public health protection with individual patient rights presents a significant ethical challenge.

Conclusions:

  • The incurable nature of prion diseases necessitates a robust ethical framework for research, diagnosis, and treatment.
  • Proactive ethical deliberation is essential to navigate the complexities of managing these transmissible neurodegenerative conditions.
  • Continued dialogue among scientists, clinicians, policymakers, and the public is vital for responsible advancement in the field.